Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
FATE THERAPEUTICS INC | Director | Stock Option (Right to Buy) | 40K | $109K | $2.73 | Jun 7, 2024 | Direct |
Gritstone bio, Inc. | Director | Stock Option (Right to Buy) | 51.8K | Jun 17, 2024 | Direct | ||
Epizyme, Inc. | Consultant and Named Executive Officer | Common Stock, par value $0.0001 | 0 | $1.41 | Aug 12, 2022 | Direct | |
Epizyme, Inc. | Consultant and Named Executive Officer | Stock Option (Right to Buy) | 0 | Aug 9, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GRTS | Gritstone bio, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
FATE | FATE THERAPEUTICS INC | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
GRTS | Gritstone bio, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
FATE | FATE THERAPEUTICS INC | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
EPZM | Epizyme, Inc. | Aug 12, 2022 | 2 | $0 | 4 | Aug 16, 2022 | Consultant and Named Executive Officer |
EPZM | Epizyme, Inc. | Aug 9, 2022 | 7 | $176K | 4 | Aug 11, 2022 | Consultant and Named Executive Officer |
GRTS | Gritstone bio, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
FATE | FATE THERAPEUTICS INC | Jun 9, 2022 | 2 | $0 | 4 | Jun 13, 2022 | Director |
FATE | FATE THERAPEUTICS INC | Jun 7, 2022 | 1 | -$18.4K | 4 | Jun 8, 2022 | Director |
FATE | FATE THERAPEUTICS INC | Jun 3, 2022 | 1 | $0 | 4/A | Jun 8, 2022 | Director |
EPZM | Epizyme, Inc. | Mar 17, 2022 | 2 | $2.95K | 4 | Mar 21, 2022 | Executive Vice President, Chief Medical and Development Officer |
EPZM | Epizyme, Inc. | Feb 7, 2022 | 1 | -$1.59K | 4 | Feb 9, 2022 | Executive Vice President, Chief Medical and Development Officer |
EPZM | Epizyme, Inc. | Feb 2, 2022 | 1 | -$3.62K | 4 | Feb 4, 2022 | Executive Vice President, Chief Medical and Development Officer |
EPZM | Epizyme, Inc. | Jan 26, 2022 | 1 | -$5.9K | 4 | Jan 28, 2022 | Executive Vice President, Chief Medical and Development Officer |
EPZM | Epizyme, Inc. | Dec 6, 2021 | 1 | -$5.22K | 4 | Dec 7, 2021 | Executive Vice President, Chief Medical and Development Officer |
EPZM | Epizyme, Inc. | Aug 16, 2021 | 2 | $0 | 4 | Aug 18, 2021 | Executive Vice President, Chief Medical and Development Officer |
GRTS | Gritstone bio, Inc. | Jun 18, 2021 | 1 | $0 | 4 | Nov 19, 2021 | Director |
FATE | FATE THERAPEUTICS INC | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
GRTS | Gritstone bio, Inc. | Jun 1, 2021 | 1 | $0 | 4 | Nov 19, 2021 | Director |
GRTS | Gritstone bio, Inc. | Jun 1, 2021 | 0 | $0 | 3 | Nov 19, 2021 | Director |